Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
T-Rex 2x Inverse Tesla Daily Target ETF
TSLZ
US Stock MarketDetailed Quotes
CADL Candel Therapeutics
- 4.940
- -0.040-0.80%
Trading Apr 28 14:19 ET
233.34MMarket Cap-2.84P/E (TTM)
5.189High4.870Low599.27KVolume5.040Open4.980Pre Close2.99MTurnover1.67%Turnover RatioLossP/E (Static)47.24MShares14.60052wk High3.52P/B177.47MFloat Cap3.78552wk Low--Dividend TTM35.93MShs Float14.780Historical High--Div YieldTTM6.40%Amplitude0.660Historical Low4.990Avg Price1Lot Size
About Candel Therapeutics Company
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Company Profile
SymbolCADL
Company NameCandel Therapeutics
Listing DateJul 27, 2021
Issue Price8.00
Founded2002
CEODr. Paul Peter Tak, M.D.,PhD
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 450
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-617-916-5445
Websitehttp://www.candeltx.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul Peter Tak, M.D.,PhD
- President, Chief Executive Officer and Director
- 1.48M
- Seshu Tyagarajan, PhD,R.A.C.
- Chief Technical and Development Officer
- --
- Dr. William Garrett Nichols, M.A.,M.D.
- Chief Medical Officer
- --
- Dr. Francesca Barone, M.D.,PhD
- Chief Scienctific Officer
- 706.88K
- Charles Schoch
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Paul B. Manning
- Chairman of the Board
- 83.19K
- Renee M. Gaeta
- Independent Director
- 55.69K
- Joseph C. Papa
- Independent Director
- 58.19K
- Christopher Martell
- Independent Director
- 67.19K
- Dr. Nicoletta Loggia, PhD,R.Ph.
- Independent Director
- 52.76K
- Dr. Gary J. Nabel, M.D.,PhD
- Independent Director
- 52.19K
- Dr. Edward J. Benz, Jr,M.D.
- Independent Director
- 56.19K
- Dr. Diem Nguyen, M.B.A.,PhD
- Independent Director
- 60.69K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
